The Biotech Capital Compass
Biotechnology & ‘Fog of Valuation’ savant
| Platform |  | Pricing | Freemium | Publishes | Daily |
|---|---|---|---|---|---|
| Issues | 264 | Founded | 2 years ago | Last Issue | 22 hours ago |
| Active | |||||
Read this Newsletter
hartajsingh1.substack.comLatest Issues
Video Recap: The Operator and the Machine — What Formula 1 Can Teach Us About Biotechnology
After an intense week, we thought we would take a slightly different route into the weekend. Perhaps even a lap around the racetrack!
And what better occasion than Kimi Antonelli becoming the youngest Formula 1 World Champion in history?...
The Biotech Watchlist: Gilead's Shohei Ohtani Moment
How lenacapavir's scientific versatility, expanding clinical applications and early commercial momentum could help Gilead renew its HIV franchise and sustain long-term leadership.
Shohei Ohtani joined the Los Angeles Dodgers as an extraord...
Video Tape Check — Part II: What Makes a Biotech Recovery Sustainable?
Building a Healthier Biotechnology Industry
Biotechnology’s recovery since the second half of 2025 has been encouraging. But stronger share prices, while welcome, do not necessarily mean that the industry’s underlying businesses have be...
Video Tape Check — Part I: Why Is Biotechnology Recovering?
A Recovery Worth Examining
Biotechnology has experienced a substantial recovery since the second half of 2025. After several difficult years, investor interest has strengthened, share prices have recovered, and the industry has begun at...
Video Recap: PolyPid and the Opportunity to Prevent Surgical Infections
Introduction
In late June, we published a newsletter examining PolyPid (NASDAQ: PYPD) and its investigational therapy, D-PLEX100, which is being developed to help prevent surgical-site infections following abdominal colorectal surgery....
Audience Metrics
Subscribers, engagement, traffic and sponsorship for The Biotech Capital Compass.
| Subscribers | Engagement | 71 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Explore More
Authors
The writers behind this newsletter.
Biotech Capital Compass breaks down complex biotech stories into valuation, risk, and narrative frameworks investors can use. Written by Hartaj Singh, a biotech analyst focused on translating innovation into investment reality.
Frequently Asked Questions
How can I access the email archive for The Biotech Capital Compass?
You can find recent issues that have been published by The Biotech Capital Compass on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does The Biotech Capital Compass have?
To see how many people subscribe to The Biotech Capital Compass, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in The Biotech Capital Compass?
Newsletter advertising can be extremely effective when it's done right. Before you pitch The Biotech Capital Compass as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like The Biotech Capital Compass?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact The Biotech Capital Compass using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to The Biotech Capital Compass?
Scroll up to where it says Related Newsletters to see other publications like The Biotech Capital Compass. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact The Biotech Capital Compass?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.